| Schedule of reconciliation of the denominators used to calculate basic EPS and diluted EPS |
The reconciliations of the denominators used to calculate basic and diluted net income (loss) per common share for the three and nine months ended December 31, 2020 and 2019, respectively, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2020 |
|
Three Months Ended December 31, 2019 |
|
Nine Months Ended December 31, 2020 |
|
Nine Months Ended December 31, 2019 |
| Basic net income (loss) per common share |
|
|
|
|
|
|
|
| Net income (loss) available to Thermon Group Holdings, Inc. |
$ |
6,175 |
|
|
$ |
6,522 |
|
|
$ |
1,928 |
|
|
$ |
14,906 |
|
| Weighted-average common shares outstanding |
33,180,562 |
|
|
32,785,753 |
|
|
33,110,877 |
|
|
32,716,317 |
|
| Basic net income (loss) per common share |
$ |
0.19 |
|
|
$ |
0.20 |
|
|
$ |
0.06 |
|
|
$ |
0.46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2020 |
|
Three Months Ended December 31, 2019 |
|
Nine Months Ended December 31, 2020 |
|
Nine Months Ended December 31, 2019 |
| Diluted net income (loss) per common share |
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) available to Thermon Group Holdings, Inc. |
|
|
|
|
$ |
6,175 |
|
|
$ |
6,522 |
|
|
$ |
1,928 |
|
|
$ |
14,906 |
|
| Weighted-average common shares outstanding |
|
|
|
|
33,180,562 |
|
|
32,785,753 |
|
|
33,110,877 |
|
|
32,716,317 |
|
| Common share equivalents: |
|
|
|
|
|
|
|
|
|
|
|
| Stock options |
|
|
|
|
2,733 |
|
|
163,357 |
|
|
21,155 |
|
|
161,420 |
|
| Restricted and performance stock units |
|
|
|
|
236,278 |
|
|
309,827 |
|
|
102,325 |
|
|
246,843 |
|
Weighted average shares outstanding – dilutive (1)
|
|
|
|
|
33,419,573 |
|
|
33,258,937 |
|
|
33,234,357 |
|
|
33,124,580 |
|
| Diluted net income (loss) per common share |
|
|
|
|
$ |
0.18 |
|
|
$ |
0.20 |
|
|
$ |
0.06 |
|
|
$ |
0.45 |
|
(1) For the three months ended December 31, 2020 and 2019, 250,668 and zero equity awards were not included in the calculation of diluted net income per common share, respectively, as they would have had an anti-dilutive effect. For the nine months ended December 31, 2020 and 2019, 246,005 and zero equity awards, respectively, were not included in the calculation of diluted net income per common share, as they would have had an anti-dilutive effect.
|